PharmacoEconomics Journal Issues 2 Research Articles in October 2019 Edition
Targeted News Service
CHAM, Switzerland, Aug. 27 -- PharmacoEconomics, a peer-reviewed journal that says it features application of pharmacoeconomics and quality-of-life assessment to optimum drug therapy and health outcomes, published two research articles on the following topics in its October 2019 edition:
* Adoption of Cost Effectiveness-Driven Value-Based Formularies in Private Health Insurance from 2010 to 2013
* Cost-Effectiveness Analysis of Non-Statin Lipid-Modifying Agents for Secondary Cardiovascular Disease Prevention Among Statin-Treated Patients in Thailand
PELOSI — Statement on Trump Administration Stealing Money from Disaster Relief to Fund Cruel Family Incarceration Policy
The Bachmann-Zeitlin Insurance Agency Insures New Drivers This Fall
Advisor News
- Benefit Costs Squeeze Schools, Driving Cuts, Tax Hikes And Difficult Tradeoffs
- Why client insurance needs could change even if their life doesn’t
- Most Gen Z investors think less than a year ahead when making financial decisions
- IRI pitches retirement agenda to Jeffries as democrats shape affordability platform
- Help child-free clients plan for their later years
More Advisor NewsAnnuity News
- Guidance, bulletin or reg? NAIC debates form of annuity illustration update
- Nationwide adds mutual fund-linked strategy to New Heights Select FIA
- NUNN INTRODUCES BILL TO CUT RED TAPE, GIVE IOWANS CLEARER INSURANCE INFORMATION
- NAIC working group pressed to accelerate annuity illustration overhaul
- State Auditor James Brown Kicks Off Life Insurance Awareness Month With Policy Locator Tool
More Annuity NewsHealth/Employee Benefits News
Life Insurance News